Andy Danielsen, chair of Mayo Clinic Ventures, has accepted the role of Mayo Clinic's chief business development officer. He succeeds James Rogers who has assumed the role of CEO, Mayo Clinic Digital Pathology. In partnership with Peter Noseworthy, MD, medical director - Business Development, Andy will lead the department's collaborative efforts to deliver strategic, innovative and mission-advancing solutions for the benefit of patients worldwide. Congrats, Andy!
Mayo Clinic Ventures
Hospitals and Health Care
Rochester, Minnesota 14,379 followers
We bring Mayo Clinic innovations to the marketplace for the benefit of patients, providers and consumers.
About us
Mayo Clinic Ventures is responsible for commercializing Mayo Clinic’s intellectual property. We develop, manage, protect and license technology that saves lives and advances patient care. Who is Mayo Clinic Ventures? Mayo Clinic Ventures is a mission-driven, global leader in research and technology commercialization housed within Mayo Clinic’s Business Development department. Our multidisciplinary team is comprised of professionals in the fields of technology licensing and IP enterprise management, business and technology development, finance, legal, operations, and admin support across our offices in Rochester, Florida and Arizona. What does Mayo Clinic Ventures do? Mayo Clinic Ventures brings together the perspective of patients, physicians and the healthcare market to find better ways to practice medicine, with new mechanisms, new drugs, new healthcare models and new procedures that are less invasive, more cost-effective and leverage the latest in personalized medicine. We are uniquely qualified to facilitate the advancement of health-related technologies to guide patient-centered solutions to complex health issues. Why do business with Mayo Clinic Ventures? Several of the most widely used medical advancements throughout the world have been developed at Mayo Clinic. Mayo Clinic Ventures is not a traditional tech transfer office — distinct in that it not only licenses Mayo Clinic’s intellectual property, but also forms product development collaborations, actively mines Mayo Clinic for ideas, teaches entrepreneurism, starts companies, runs a business accelerator and participates in a multi-million dollar venture and growth fund that supports economic development. While Mayo Clinic Ventures cannot guarantee that all disclosed inventions and discoveries will be patented or commercialized, we commit our resources to ensure that each technology is given appropriate opportunities to realize its potential. We invite you to make medical history with us.
- Website
-
https://businessdevelopment.mayoclinic.org/
External link for Mayo Clinic Ventures
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Rochester, Minnesota
- Founded
- 1985
- Specialties
- Invention Disclosure, Tech Transfer, Commercialization, Patent Filing, Intellectual Property, BioPharma, Research Tools, Business Development, Healthcare IT, Radiology, Devices, Cardiology, Orthopedics, and Diagnostics
Updates
-
Stay connected with the latest news in healthcare technology, innovation, events and more with Mayo Clinic's Department of Business Development monthly newsletter. Sign up today and don't miss the newest edition coming next week.
-
Researchers at Mayo Clinic have developed an AI algorithm capable of assisting physicians in pinpointing seizure hotspots in a patient's brain. This new tool allows clinicians to make quicker, more informed treatment decisions. #innovation #AI #neurology
Mayo Clinic researchers develop new AI tools to reveal seizure hotspots, improve patient care - Mayo Clinic News Network
newsnetwork.mayoclinic.org
-
Mayo Clinic has developed a thyroid stimulating hormone receptor (TSHR) chimeric antigen receptor (CAR) T-cell therapy to target aggressive thyroid cancers and is seeking an industry collaborator to bring this technology to market. #innovation #collaboration
Technology licensing and commercialization opportunities.
https://businessdevelopment.mayoclinic.org
-
Vyriad, a Mayo Clinic portfolio company, is teaming up with Novartis to revolutionize CAR-T cell therapy through a groundbreaking in vivo approach. https://lnkd.in/gQWUrnyr #collaboration #innovation
Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies
prnewswire.com
-
Researchers at Mayo Clinic are exploring new ways to employ #AI to generate actionable, unobtrusive pharmacogenomic alerts - technology aided predictions of patient responses to specific medications. #innovation
Mayo researchers develop AI-enhanced strategy to personalize medication alerts - Mayo Clinic News Network
newsnetwork.mayoclinic.org
-
Mayo Clinic collaborator Cobot - Collaborative Robotics, Inc has announced the launch of their Proxie robot, an adaptable robot designed to assist in material handling tasks. Mayo Clinic Laboratories will be participating in the Proxie pilot program. #collaboration #innovation
Introducing Proxie, Cobot's Collaborative Robot, Built for the Real World
prnewswire.com
-
This unique biotech model will focus on validating high-potential ideas early to ensure only the most promising projects move forward—maximizing impact while minimizing risk. Why it matters: 🔬 Innovation: Leveraging decades of experience to identify and advance revolutionary ideas. 🌍 Impact: Addressing critical gaps in cancer treatment and beyond, inspired by cutting-edge biology. 💡 Collaboration: Fueled by a world-class network of scientists, investors and institutions to include Mayo Clinic. https://lnkd.in/eaUJsaE8 / Jupiter Bioventures #innovation #collaboration #healthcare
Industry Veterans Announce Jupiter Bioventures, a Biotechnology Venture Foundry that Turns Novel Science into Transformational Companies
globenewswire.com
-
Congratulations to James Rogers as he wraps up his tenure as Chief Business Development Officer and moves into his new role as CEO of Mayo Clinic's Digital Pathology initiative. Your leadership has made Business Development what it is today, and we wish you the best in your next endeavor.
-
-
-
-
-
+2
-
-
Physicians at Mayo Clinic have developed a new intra-operative brain mapping tool to achieve better outcomes for patients with epilepsy. With higher resolution and accuracy, this tool allows for dynamic testing during surgery to increase precision and improve patient outcomes. #innovation #collaboration
Novel solutions for complex challenges.
https://businessdevelopment.mayoclinic.org